Azerbaijan National Academy of Sciences

The first batch of the drug against COVID-19 Avifavir, which blocks the reproduction of the virus, was received in Russian hospitals. The first medicine was received by medical institutions in Moscow, Leningrad, Novgorod, Kirov, Nizhny Novgorod regions, Tatarstan and Yekaterinburg. In total this month it is planned to deliver 60 thousand courses of Avifavira. If necessary, the volume of production will increase to two million courses per year.

poisknews.ru